We performed extensive phenotyping, including body composition, insulin sensitivity with euglycemic clamps, glucose tolerance with oral glucose load, metabolic risk factors, and cytokines, and transcriptomic analysis in liver biopsies from 58 individuals with or without a diagnosis of NAFLD and NASH. The gene discussed is INS; the disease is metabolic dysfunction-associated steatohepatitis.